Диагностика первичного гиперальдостеронизма

Лекция посвящена проблеме диагностики первичного гиперальдостеронизма, дифференциальной диагностики различных нозологических форм данного заболевания. Описаны этапы диагностики, основные функциональные (подтверждающие) тесты, а также инструментальные методы исследования, применяемые у пациентов с данной патологией.

первичный гиперальдостеронизм, альдостерон-рениновое соотношение, подтверждающий тест, сравнительный селективный забор крови из надпочечниковых вен

1. Young W.F. Jr. Primary aldosteronism: management issues. Ann N Y AcadSci 2002; 970: 61-76.

2. Hiramatsu K., Yamada T., Yukimura Y. et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Int Med 1981; 141: 1589-1593.

3. Mulatero P., Stowasser M., Loh K.C. et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. Clin Endocrinol Metab 2004; 89: 1045-1050.

4. Ветшев П.С., Шкроб О.С., Ипполитов Л.И., Полунин Г.В. Диагностика и хирургическое лечение артериальных гипертензий надпочечникового генеза. Хирургия 2001; 1: 33-40.

5. Подзолков В.И., Родионов А.В. Первичный гиперальдостеронизм: диагностика и лечение. Артериальная гипертензия 2004; 10: 2.

6. Young W.F.Jr., Klee G.G. Primary aldosteronism. Diagnostic evaluation. Endocrinology and Metabolism. Clin North Am 1988; 17: 367-395.

7. Labinson P.T., White W.B., Tendler B.E., Mansoor G.A. Primary hyperaldosteronism associated with hypertensive emergencies. Am J Hypertens 2006; 9: 623-627.

8. Blumenfeld J.D., Sealey J.E., Schlussel Y. et al. Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med 1994; 121: 877-885.

9. Павленко А.К., Фадеев В.В., Мельниченко Г.А. Диагностика первичного гиперальдостеронизма. Пробл эндокринол 2001; 2: 15-25.

10. Rossi G.P., Bernini G., Caliumi C. et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006; 48: 2293-2300.

11. Rossi G.P., Bernini G., Desideri G. et al. Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension 2006; 48: 232-238.

12. Дедов И.И. Болезни органов эндокринной системы. М: Медицина 2000.

13. Д Хирургия надпочечников. Под ред. А.П. Калинина, Н.А. Майстренко. М 2000.

14. Чихладзе Н. Первичный гиперальдостеронизм. Врач 1992; 5: 21-23.

15. An Endocrine Society Clinical Practice Guidelines. Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism. J Clin Endocrinol Metab 2008; 93: 9: 3266-3281.

16. McKenna T.J., Sequeira S.J., Heffernan A. et al. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosteroneaxis, including primary hyperaldosteronism. J Clin Endocrinol Metab 1991; 73: 952-957.

17. Stowasser M., Gordon R.D., Gunasekera T.G. et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after ‘non-selective' screening of hypertensive patients. J Hypertens 2003; 21: 2149-2157.

18. Gallay B.J., Ahmad S., Xu L. et al. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis 2001; 37: 699-705.

19. Gordon R.D., Stowasser M., Tunny T.J. et al. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994; 21: 315-318.

20. Lim P.O., Dow E., Brennan G. et al. High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 2000; 14: 311-315.

21. Loh K.C., Koay E.S., Khaw M.C. et al. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000; 85: 2854-2859.

22. Tiu S.C., Choi C.H., Shek C.C. et al. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab 2005; 90: 72-78.

23. Young W.F. Jr. Primary aldosteronism: update on diagnosis and treatment. The Endocrinologist 1997; 7: 213-221.

24. Young W.F. Jr. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 2007; 66: 607-618.

25. Gordon R.D. The challenge of more robust and reproducible methodology in screening for primary aldosteronism. J Hypertens 2004; 22: 251-255.

26. Kaplan N.M. The current epidemic of primary aldosteronism: causes and consequences. J Hypertens 2004; 22: 863-869.

27. Schwartz G.L., Chapman A.B., Boerwinkle E. et al. Screening for primary aldosteronism: implications of an increased plasma aldosterone/renin ratio. Clin Chem 2002; 48: 1919-1923.

28. Rossi G.P., Rossi E., Pavan E. et al. Screening for primary aldosteronism with a logistic multivariate discriminant analysis. Clin Endocrinol 1998; 49: 713-723.

29. Kaplan N.M. Caution about the overdiagnosis of primary aldosteronism. Mayo Clin Proc 2001; 76: 875-876.

30. Padfield P.L. Primary aldosteronism, a common entity the myth persists. J Hum Hypertens 2002; 16: 159-162.

31. Gordon R.D., Stowasser M., Klemm S.A., Tunny T.J. Primary aldosteronism and other forms of mineralocorticoid hypertension. In: J.D. Swales (ed.). Textbook of hypertension. London: Blackwell Scientific 1994; 865-892.

32. Mulatero P., Dluhy R.G., Giacchetti G. et al. Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol Metab 2005; 16: 114-119.

33. Stowasser M., Gordon R.D., Rutherford J.C. et al. Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst 2001; 2: 156-169.

34. Hambling C., Jung T., Gunn A. et al. Re-evaluation of the captopril test for the diagnosis of primary hyperaldosteronism. Clin Endocrinol 1992; 36: 499-503.

35. Mulatero P., Bertello C., Garrone C. et al. Captopril test can give misleading results in patients with suspect primary aldosteronism. Hypertension 2007; 50: e26-27.

36. Muratani H., Abe I., Tomita Y. et al. Is single oral administration of captopril beneficial in screening for primary aldosteronism Am Heart J 1986; 112: 361-367.

37. Mulatero P., Milan A., Fallo F. et al. Comparison of Confirmatory Tests for the Diagnosis of Primary Aldosteronism. J Clin Endocrinol Metab 2006; 91: 7: 2618-2623.

38. Rossi G.P., Belfiore A., Bernini G. et al. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 2007; 50: 424-431.

39. Espiner E.A., Ross D.G., Yandle T.G. et al. Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling. J Clin Endocrinol Metab 2003; 88: 3637-3644.

40. Phillips J.L., Walther M.M., Pezzullo J.C. et al. Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab 2000; 85: 4526-4533.

41. Ganguly A., Dowdy A.J., Luetscher J.A., Melada G.A. Anomalous postural response of plasma aldosterone concentration in patients with aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab 1973; 36: 401-404.

42. Gordon R.D., Gomez-Sanchez C.E., Hamlet S.M. et al. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension. J Hypertens Suppl 1987; 5: S103-106.

43. Ветшев П.С., Ипполитов Л.И., Королева И.М., Коваленко Е.И. Возможности компьютерной томографии в диагностике новообразований нaдпoчeчникoв. Хиpypгия 2002; 6: 9-14.

44. Young W.F. Jr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 2007; 356: 601-610.

45. Daunt N. Adrenal vein sampling: how to make it quick, easy, and successful. RadioGraphics 2005; 25: Suppl 1: S143-S158.

46. Rossi G.P., Sacchetto A., Chiesura-Corona M. et al. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 2001; 86: 1083-1090.

47. Kloos R.T., Gross M.D., Francis I.R. et al. Incidentally discovered adrenal masses. Endocr Rev 1995; 16: 460-484.

48. Lingam R.K., Sohaib S.A., Rockall A.G. et al. Diagnostic performance of CT versus MR in detecting aldosterone-producing adenoma in primary hyperaldosteronism (Conn's syndrome). Eur Radiol 2004; 14: 1787-1792.

49. Lumachi F., Marzola M.C., Zucchetta P. et al. Non-invasive adrenal imaging in primary aldosteronism: sensitivity and positive predictive value of radiocholesterol scintigraphy, CT scan and MRI. Nucl Med Commun 2003; 24: 683-688.

50. Gordon R.D. Diagnostic investigations in primary aldosteronism. In: A. Zanchetti (ed.). Clinical medicine series on hypertension. Maidenhead, UK: McGraw-Hill International 2001; 101-111.

51. Nwariaku F.E., Miller B.S., Auchus R. et al. Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome. Arch Surg 2006; 141: 497-502.

52. Young W.F. Jr, Stanson A.W., Thompson G.B. et al. Role for adrenal venous sampling in primary aldosteronism. Surgery 2004; 136: 1227-1235.

53. Gross M.D., Shapiro B., Shreve P. Radionuclide imaging of the adrenal cortex. Q J Nucl Med 1999; 43: 224-232.

54. Nakahama H., Fukuchi K., Yoshihara F. et al. Efficacy of screening for primary aldosteronism by adrenocortical scintigraphy without discontinuing antihypertensive medication. Am J Hypertens 2003; 16: 725-728.

55. Nocaudie-Calzada M., Huglo D., Lambert M. et al. Efficacy of iodine-131 6beta-methyl-iodo-19-nor-cholesterol scintigraphy and computed tomography in patients with primary aldosteronism. Eur J Nucl Med 1999; 26: 1326-1332.

56. Nomura K., Kusakabe K., Maki M. et al. Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasone-suppression scintigraphy: relationship to adenoma size and functional activity. J Clin Endocrinol Metab 1990; 71: 825-830.

57. Mansoor G.A., Malchoff C.D., Arici M.H. et al. Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning. Am J Hypertens 2002; 15: 459-464.

58. Biglieri E.G., Schambelan M. The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism. J Clin Endocrinol Metab 1979; 49: 87-91.